Skip to main content
Caplight Logo









Cellistic

Cellistic

Private
Mont-Saint-GuibertHealthcare & Life Scienceshttps://www.cellistic.com/

Last Round

Corporate Funding

Nov 16, 2021

Total Funding Raised

$60M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cellistic is a biotechnology company that provides contract development and manufacturing organization (CDMO) services specializing in the process development and manufacturing of cell therapies based on human induced pluripotent stem cell (iPSC) technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOiPSCcell therapy manufacturingbioprocess engineeringinduced pluripotent stem cellcontract developmentGMP manufacturingcell line developmentbiotech manufacturinganalytical developmentgene editingbioprocessingclinical-grade cellscell therapy scale-upbiotech CDMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellistic Comparables

Compare Cellistic with similar companies based on industry and business-model similarity.

Cellistic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RoslinCT
81%
Cellab CDMO
79%
I Peace, Inc.
79%

Cellistic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 16, 2021

Key People

Founding team and executive leadership

Stefan Braam

President and CTO

Executive Team

Marc Lourtie

Group CFO

Executive Team

Cellistic Investors

Notable investors and investment history

Cellistic investors
InvestorRounds
Biospring PartnersCorporate Funding
KinicitiCorporate Funding
Welsh, Carson, Anderson & StoweCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 57% MoM to 5.3K.

  • Nov 8, 2025

    Monthly visitors increased 88% MoM.

Cellistic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellistic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellistic's valuation, stock price, and market status.

Firmographic Details

HeadquartersMont-Saint-Guibert
Employee Range85
Year Founded2022
Last FundingNov 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?